The agreement includes plans for distribution, technology transfer, local manufacturing, new pharmaceutical product development
New platform powered by Opentrons expands lab automation to accelerate scientific discovery
The Medical Countermeasures Strategy focuses on strengthening the EU’s preparedness for health crises
The UK authorization is based on positive results from the Phase III OASIS-1, -2, and -3 trials
Xtandi is approved in over 80 countries, including the U.S., EU, and Japan
The Stryker Mako Robotic System uses artificial intelligence to improve surgical accuracy with real-time guidance, personalized planning, and precise execution
The first project will focus on developing an AI-based platform for the sterically guided design of bispecific antibodies
These medicines are essential in preventing RhD immunisation during pregnancy
CSIR-IGIB advances indigenous CRISPR Trials on sickle cell anaemia, anti-microbial resistance, liver fibrosis and rare disorders
InnoCell is the brand name for Mitsui Chemicals’ cell culture products and services
Subscribe To Our Newsletter & Stay Updated
